Polaris AI Pharma Corp. (KOSDAQ:041910)

Market Cap	98.96B +17.3%
Revenue (ttm)	63.94B +8.7%
Net Income	989.48M -92.8%
EPS	84.72 -92.8%
Shares Out	13.28M
PE Ratio	87.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	297,352
Average Volume	2,946,160
Open	7,420.00
Previous Close	7,490.00
Day's Range	7,240.00 - 7,520.00
52-Week Range	5,290.00 - 10,200.00
Beta	0.73
RSI	53.61
Earnings Date	n/a

About Polaris AI Pharma

Polaris AI Pharma Corp. engages in the manufacture and sale of pharmaceuticals products in South Korea and internationally. It also offers its products for various therapeutic categories, such as diagnostic acid, antidiabetic, anti-depressants, and cholinergic. The company was formerly known as EstechPharma Co., Ltd. and changed its name to Polaris AI Pharma Corp. in March 2024. The company was founded in 1996 and is headquartered in Hwaseong-si, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 160
• Stock Exchange: KOSDAQ
• Ticker Symbol: 041910

Financial Performance

In 2021, Polaris AI Pharma's revenue was 60.40 billion, a decrease of -1.51% compared to the previous year's 61.32 billion. Earnings were 6.87 billion, a decrease of -56.30%.